Stock-outs of antiretroviral drugs and coping strategies used to prevent changes in treatment regimens in Kinondoni District, Tanzania: a cross-sectional study
Open Access
- 22 April 2014
- journal article
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 7 (1) , 3
Abstract
Since 2004, the government of Tanzania has been rolling out antiretroviral treatment programs all over the country. However, the capacity of the health system to cope with the rapid scale-up of these programs is a major concern, and problems may result in drug stock-outs that force changes in treatment regimens. This study aims to explore stock-outs of antiretroviral drugs and further determine the coping strategies employed to prevent changes in treatment regimens in HIV/AIDS care and treatment clinics in Kinondoni District, Dar es Salaam, Tanzania. A cross-sectional study was conducted in 20 HIV/AIDS care and treatment clinics. Interviews were conducted with the person in charge and a member of the pharmacy staff from each clinic using a pre-tested semi-structured interview guide. Verbal responses were transcribed, coded and analysed by thematic approach. Quantitative data were analysed using Excel spreadsheet (Microsoft Excel®, Microsoft Corporation). The total number of clients enrolled in the visited clinics was 32,147, of whom 20,831 (64.8%) had already been initiated onto antiretroviral therapies (ART). Stock-out of antiretroviral drugs was reported in 16 out of the 20 clinics, causing 210 patients to change their ART regimens, during the 12 months preceding the survey. Inefficient supply systems, quantification problems and short expiry duration were cited as the main causes of stock-outs. The coping strategies utilised to prevent changes in ART regimens were: shortening of the refill period, borrowing and moving patients to other clinics. Changes in ART regimens due to stock-outs of antiretroviral drugs occurred in a small but significant number of patients. This increases the risk of the emergence of drug-resistant HIV strains. Healthcare workers use various coping strategies to prevent changes in ART regimens but, unfortunately, some of these strategies are likely to increase patient-borne costs, which may discourage them from attending their routine clinics, hence leading to unplanned treatment interruptions.Keywords
This publication has 14 references indexed in Scilit:
- Facing up to programmatic challenges created by the HIV/AIDS epidemic in sub‐Saharan AfricaJournal of the International AIDS Society, 2011
- High prevalence of HIV‐1 drug resistance among patients on first‐line antiretroviral treatment in Lomé, TogoJournal of the International AIDS Society, 2011
- Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Côte d'IvoirePLOS ONE, 2010
- The high cost of second-line antiretroviral therapy for HIV/AIDS in South AfricaAIDS, 2010
- Estimating the Capacity for ART Provision in Tanzania with the Use of Data on Staff Productivity and Patient LossesPLOS ONE, 2009
- A strategy to improve skills in pharmaceutical supply management in East Africa: the regional technical resource collaboration for pharmaceutical managementHuman Resources for Health, 2008
- Eearly loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countriesBulletin of the World Health Organization, 2008
- Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, UgandaAIDS, 2007
- Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in AfricaAIDS Care, 2007
- Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case reportThe Lancet, 2005